Heron Bay Capital Management Sells 877 Shares of UnitedHealth Group Incorporated $UNH

Heron Bay Capital Management lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 53.1% during the 2nd quarter, Holdings Channel.com reports. The firm owned 776 shares of the healthcare conglomerate’s stock after selling 877 shares during the period. Heron Bay Capital Management’s holdings in UnitedHealth Group were worth $242,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. Cowa LLC bought a new stake in UnitedHealth Group during the 2nd quarter worth approximately $289,000. Meridian Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 3.3% during the 2nd quarter. Meridian Wealth Advisors LLC now owns 13,361 shares of the healthcare conglomerate’s stock valued at $4,168,000 after purchasing an additional 433 shares during the period. Richard W. Paul & Associates LLC boosted its holdings in UnitedHealth Group by 81.0% in the 2nd quarter. Richard W. Paul & Associates LLC now owns 4,003 shares of the healthcare conglomerate’s stock worth $1,249,000 after buying an additional 1,792 shares during the period. New World Advisors LLC raised its holdings in UnitedHealth Group by 84.5% during the second quarter. New World Advisors LLC now owns 950 shares of the healthcare conglomerate’s stock valued at $296,000 after acquiring an additional 435 shares during the period. Finally, Bahl & Gaynor Inc. boosted its stake in shares of UnitedHealth Group by 145.7% in the second quarter. Bahl & Gaynor Inc. now owns 680,777 shares of the healthcare conglomerate’s stock worth $212,382,000 after acquiring an additional 403,729 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 2.5%

UNH opened at $319.40 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a 50-day moving average of $344.69 and a 200 day moving average of $316.94. The firm has a market cap of $289.32 billion, a P/E ratio of 16.67, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.15 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Mizuho boosted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Bank of America boosted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Robert W. Baird restated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, Barclays increased their price target on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.